Loading
Latest filing published 14 Aug 2025 for Design Therapeutics, Inc., €1.5M. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Arsani William in Design Therapeutics, Inc., where the filings describe the role as board member. The record holds 6 filings, for trades running from 30 March 2021 to 13 August 2025.
Market trades split into 3 purchases (€1.5M) and 2 sales (€4.7M). The net balance comes to €3.2M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings no purchases and 1 sale.
A typical purchase (the median) is worth €523k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 14 August 2025 came the latest disclosure, an open-market sale for €1.5M in Design Therapeutics, Inc. The last purchase on record was published on 30 August 2023, which is 1,145 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations